Predictors of Financial Toxicity Risk Among Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS–HIPEC)
Crossref DOI link: https://doi.org/10.1245/s10434-023-14577-y
Published Online: 2023-12-04
Published Print: 2024-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ciftci, Yusuf
Radomski, Shannon N.
Johnston, Fabian M.
Greer, Jonathan B. http://orcid.org/0000-0001-8968-9710
Text and Data Mining valid from 2023-12-04
Version of Record valid from 2023-12-04
Article History
Received: 21 August 2023
Accepted: 27 October 2023
First Online: 4 December 2023